Skip to main content
AAPS Open
Fig. 7 | AAPS Open

Fig. 7

From: Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections

Fig. 7

Experimental set up for heating 100 mg of Yomesan powder warmed in a 20 mL scintillation vial equipped with a thermocouple, placed in the powder, and heated slowly on a heating plate. Heating rates and HA (orange) and HB (blue) transitions each observed by condensation on a cover glass (Inset A). Held at 200 °C, niclosamide appeared to recrystallize on the sides of the vial (Inset B)

Back to article page